Table 2 Recommendations for antithrombotic treatments for various medical conditions

Medical condition	Recommended treatment
Coronary stent implantation	DAT for 1 month after BMS; 6–12 months after DES
Atrial fibrillation	For CHADS₂ ⩾2: OAC indefinitely
Mechanical heart valves	OAC indefinitely
Venous thromboembolism	OAC at least 3 months (see text)
Left ventricular thrombus	OAC at least 3 months (see text)
Heart failure	Routine use of anticoagulation/antithrombotic therapy not well established (see text)

BMS, bare metal stent; DAT, dual antiplatelet therapy consisting of aspirin and clopidogrel; DES, drug eluting stent; OAC, oral anticoagulation with a coumarin derivate.